Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto In ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a generic version of liraglutide manufactured by Hikma ...

PARSIPPANY, N.J. (AP) -- Generic drugmaker Actavis Inc. said Tuesday it has filed an application with federal regulators to market a generic version of the anti-inflammatory drug Rayos. Rayos is ...

Generic drugs contain the same active ingredient as their brand-name counterparts. However, they usually cost much less than the brand-name version. Before the Food and Drug Administration (FDA) ...

WASHINGTON – Makers of expensive brand-name drugs scored a victory when the United States’ new trade deal with Canada and Mexico included language preventing generic copies of their prescription ...

Health Canada is taking longer to assess generic drug applications, lengthening the wait until the cheaper pharmaceuticals can come to market, new data show. The federal regulator’s delays mean that ...

Background: Demonstration of equivalent amounts of the same active pharmaceutical ingredient (API) between generic and innovator products (pharmaceutical equivalence) is a basic requirement of ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company, today announced the advancement of two key strategic ...

WASHINGTON — Pharmaceutical giant Eli Lilly will introduce a substantially cheaper generic version of its insulin analogue Humalog – marking the first time a generic insulin analogue has ever been ...

Tesla’s attempt to trademark the term “Robotaxi” in reference to its vehicles has been refused by the U.S. Patent and Trademark Office for being too generic, according to a new filing. Another ...

Momenta Pharmaceuticals MNTA, -1.92% today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Abbreviated New Drug Application (ANDA) for a three-times-a-week ...